Viw Magazine

The Times


.

AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license

Application for drug marketing registration duly submitted Super heavyweight items are expected to drive performance soaring

HONG KONG SAR - Media OutReach Newswire – 1 November 2024 - AIM Vaccine (06660.HK) announced on 1st November that the application for drug marketing registration of the Company's independently developed 13-valent pneumonia conjugate vaccine has been submitted to the National Medical Products Administration.

Read more …

LifeStyle

What to Consider Before Choosing an Illuminated Mirror

An LED mirror combines a reflective surface with integrated illumination, making it useful in bathro...

How to Clear a Deceased Estate: A Gentle, Practical Guide for Sydney Families

Losing a loved one is hard enough. Then, often within weeks, families are faced with the task of s...

Science Tutoring Sydney: Building Strong Foundations in Science

Students and parents looking for science tutoring Sydney often want support that combines clear te...

Gym Solutions: How to Create a Practical Home Workout Space

Creating a workout area at home can make regular exercise more convenient, particularly for people...